• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗菌治疗对肠道微生物组的影响。

Impact of antimicrobial therapy on the gut microbiome.

机构信息

Accelerate Diagnostics, Inc., Scientific Affairs, Tucson, AZ, USA.

Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, The Netherlands.

出版信息

J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i6-i15. doi: 10.1093/jac/dky530.

DOI:10.1093/jac/dky530
PMID:30690540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6382031/
Abstract

The gut microbiome is now considered an organ unto itself and plays an important role in health maintenance and recovery from critical illness. The commensal organisms responsible for the framework of the gut microbiome are valuable in protection against disease and various physiological tasks. Critical illness and the associated interventions have a detrimental impact on the microbiome. While antimicrobials are one of the fundamental and often life-saving modalities in septic patients, they can also pave the way for subsequent harm because of the resulting damage to the gut microbiome. Contributing to many of the non-specific signs and symptoms of sepsis, the balance between the overuse of antimicrobials and the clinical need in these situations is often difficult to delineate. Given the potency of antimicrobials utilized to treat septic patients, the effects on the gut microbiome are often rapid and long-lasting, in which case full recovery may never be observed. The overgrowth of opportunistic pathogens is of significant concern as they can lead to infections that become increasingly difficult to treat. Continued research to understand the disturbances within the gut microbiome of critically ill patients and their outcomes is essential to help develop future therapies to circumvent damage to, or restore, the microbiome. In this review, we discuss the impact of the antimicrobials often used for the treatment of sepsis on the gut microbiota.

摘要

肠道微生物组现在被认为是一个独立的器官,在维持健康和从重病中恢复方面发挥着重要作用。负责肠道微生物组框架的共生生物在预防疾病和各种生理任务方面具有重要价值。严重疾病和相关干预措施对微生物组有不利影响。虽然抗生素是脓毒症患者基本且经常是救命的治疗方法之一,但由于抗生素对肠道微生物组造成的损害,它们也可能为随后的伤害铺平道路。肠道微生物组的平衡在许多非特异性症状和体征中起着重要作用,在这些情况下,抗生素的过度使用和临床需求之间的平衡往往难以确定。鉴于用于治疗脓毒症患者的抗生素的效力,抗生素对肠道微生物组的影响通常是迅速而持久的,在这种情况下,可能永远无法观察到完全恢复。机会性病原体的过度生长令人严重关切,因为它们会导致感染,使治疗变得越来越困难。继续研究以了解重症患者肠道微生物组的紊乱及其结果,对于帮助开发未来的治疗方法以避免或恢复微生物组至关重要。在这篇综述中,我们讨论了常用于治疗脓毒症的抗生素对肠道微生物群的影响。

相似文献

1
Impact of antimicrobial therapy on the gut microbiome.抗菌治疗对肠道微生物组的影响。
J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i6-i15. doi: 10.1093/jac/dky530.
2
Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.重症监护患者接受选择性消化道去污染与健康受试者的肠道微生物群和耐药组比较分析。
Microbiome. 2017 Aug 14;5(1):88. doi: 10.1186/s40168-017-0309-z.
3
Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study.危重症患者肠道微生物群失调存在较大个体差异:一项初步研究。
Intensive Care Med. 2017 Jan;43(1):59-68. doi: 10.1007/s00134-016-4613-z. Epub 2016 Nov 11.
4
Sepsis and the Microbiome: A Vicious Cycle.脓毒症与微生物组:恶性循环。
J Infect Dis. 2021 Jun 16;223(12 Suppl 2):S264-S269. doi: 10.1093/infdis/jiaa682.
5
Antibiotic perturbation of the preterm infant gut microbiome and resistome.抗生素对早产儿肠道微生物群和耐药基因组的干扰。
Gut Microbes. 2016 Sep 2;7(5):443-9. doi: 10.1080/19490976.2016.1218584. Epub 2016 Jul 29.
6
Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease.肠道免疫、肠道微生物群与脓毒症:对疾病病菌学说的重新思考
Exp Biol Med (Maywood). 2017 Jan;242(2):127-139. doi: 10.1177/1535370216669610. Epub 2016 Oct 4.
7
Not Just Antibiotics: Is Cancer Chemotherapy Driving Antimicrobial Resistance?不仅是抗生素:癌症化疗是否正在推动抗微生物药物耐药性?
Trends Microbiol. 2018 May;26(5):393-400. doi: 10.1016/j.tim.2017.10.009. Epub 2017 Nov 13.
8
Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?治疗肠道微生物群是改善肝硬化治疗效果的关键吗?
Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):1-2. doi: 10.1080/17474124.2019.1543587. Epub 2018 Nov 13.
9
The microbiome: implications for perioperative and critical care.微生物组:对围手术期和重症监护的影响。
Curr Opin Anaesthesiol. 2019 Jun;32(3):412-420. doi: 10.1097/ACO.0000000000000734.
10
An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness.深入理解抗生素在危重病中引起的大规模代谢变化。
Gut Microbes. 2021 Jan-Dec;13(1):1993598. doi: 10.1080/19490976.2021.1993598.

引用本文的文献

1
High-dose multi-strain Bacillus probiotics enhance treatment and reduce antibiotic usage in children with persistent diarrhea through immune and microbiota modulation.高剂量多菌株芽孢杆菌益生菌通过调节免疫和微生物群来增强持续性腹泻儿童的治疗效果并减少抗生素使用。
Sci Rep. 2025 Aug 18;15(1):30231. doi: 10.1038/s41598-025-15199-y.
2
Bifidobacteria in antibiotic-associated dysbiosis: restoring balance in the gut microbiome.抗生素相关性菌群失调中的双歧杆菌:恢复肠道微生物群的平衡
World J Microbiol Biotechnol. 2025 Aug 6;41(8):297. doi: 10.1007/s11274-025-04517-1.
3
Gastrointestinal tract, its pathophysiology and models: A "quick" reference guide to translational studies.胃肠道、其病理生理学及模型:转化研究的“快速”参考指南。
World J Gastroenterol. 2025 Jul 28;31(28):108297. doi: 10.3748/wjg.v31.i28.108297.
4
NO: a key player in microbiome dynamics and cancer pathogenesis.一氧化氮:微生物群动态和癌症发病机制中的关键因素。
Front Cell Infect Microbiol. 2025 Jun 26;15:1532255. doi: 10.3389/fcimb.2025.1532255. eCollection 2025.
5
Risk factors associated with community colonization of extended-spectrum cephalosporin-resistant Enterobacterales from an antibiotic resistance in communities and hospitals (ARCH) study, Guatemala.来自危地马拉一项社区与医院抗生素耐药性(ARCH)研究中与耐超广谱头孢菌素肠杆菌科细菌社区定植相关的危险因素。
Sci Rep. 2025 May 29;15(1):18925. doi: 10.1038/s41598-025-03379-9.
6
Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies.重症监护病房中的抗生素降阶梯治疗:基本原理与潜在策略
Antibiotics (Basel). 2025 May 3;14(5):467. doi: 10.3390/antibiotics14050467.
7
Management and Prevention of Multidrug-Resistant Bacteria in War Casualties.战争伤员中多重耐药菌的管理与预防
Trop Med Infect Dis. 2025 May 8;10(5):128. doi: 10.3390/tropicalmed10050128.
8
Comparison of initial empirical antibiotic regimens in severe community-acquired pneumonia: a network meta-analysis.重症社区获得性肺炎初始经验性抗生素治疗方案的比较:一项网状Meta分析。
BMC Pulm Med. 2025 May 20;25(1):246. doi: 10.1186/s12890-025-03695-w.
9
The Impact of Antibiotic Therapy on Intestinal Microbiota: Dysbiosis, Antibiotic Resistance, and Restoration Strategies.抗生素治疗对肠道微生物群的影响:生态失调、抗生素耐药性及恢复策略
Antibiotics (Basel). 2025 Apr 3;14(4):371. doi: 10.3390/antibiotics14040371.
10
The microbiome's influence on obesity: mechanisms and therapeutic potential.微生物群对肥胖的影响:机制与治疗潜力。
Sci China Life Sci. 2025 Mar;68(3):657-672. doi: 10.1007/s11427-024-2759-3. Epub 2024 Nov 28.

本文引用的文献

1
Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial.通气患者中具有抗生素耐药微生物的去污策略和血流感染:一项随机临床试验。
JAMA. 2018 Nov 27;320(20):2087-2098. doi: 10.1001/jama.2018.13765.
2
Does antibiotic choice for the treatment of suspected late-onset sepsis in premature infants determine the risk of developing necrotising enterocolitis? A systematic review.治疗早产儿疑似晚发型败血症时抗生素的选择是否会决定发生坏死性小肠结肠炎的风险?一项系统综述。
Early Hum Dev. 2018 Aug;123:6-10. doi: 10.1016/j.earlhumdev.2018.06.009. Epub 2018 Jul 3.
3
The impact of antibiotic use on transmission of resistant bacteria in hospitals: Insights from an agent-based model.抗生素使用对医院耐药菌传播的影响:基于代理的模型研究。
PLoS One. 2018 May 14;13(5):e0197111. doi: 10.1371/journal.pone.0197111. eCollection 2018.
4
Extensive impact of non-antibiotic drugs on human gut bacteria.非抗生素药物对人体肠道细菌的广泛影响。
Nature. 2018 Mar 29;555(7698):623-628. doi: 10.1038/nature25979. Epub 2018 Mar 19.
5
Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients.头孢曲松促进了住院患者肠道菌群中产 AmpC 酶肠杆菌科细菌的出现。
Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):417-421. doi: 10.1007/s10096-018-3186-x. Epub 2018 Jan 10.
6
The microbiome of the critically ill patient.危重症患者的微生物组。
Curr Opin Crit Care. 2018 Feb;24(1):49-54. doi: 10.1097/MCC.0000000000000469.
7
Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection.医院级别抗生素使用量与新发医疗机构获得性艰难梭菌感染的相关性。
Am J Infect Control. 2018 Mar;46(3):270-275. doi: 10.1016/j.ajic.2017.09.015. Epub 2017 Nov 21.
8
Association between prior antibiotic therapy and subsequent risk of community-acquired infections: a systematic review.抗生素治疗史与社区获得性感染后续风险的关联:系统评价。
J Antimicrob Chemother. 2018 Feb 1;73(2):287-296. doi: 10.1093/jac/dkx374.
9
A randomized synbiotic trial to prevent sepsis among infants in rural India.一项在印度农村地区预防婴儿败血症的随机共生元试验。
Nature. 2017 Aug 24;548(7668):407-412. doi: 10.1038/nature23480. Epub 2017 Aug 16.
10
Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone.头孢曲松治疗患者肠道菌群中抗菌药物耐药性的扩增。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00473-17. Print 2017 Nov.